• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NXS
Click for more information
4.84% 32.5¢

NEXT SCIENCE LIMITED - News & Media

Market Cap $94.80M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Instruments & Supplies

Next Science Limited is an Australia-based medical technology company. The Company’s... Next Science Limited is an Australia-based medical technology company. The Company’s primary focus is on the development and commercialization of its proprietary XBIO technology to reduce the impact of biofilm-based infections on human health. XBIO is a non-toxic technology with an efficacy in eradicating both biofilm-based and free-floating bacteria. The Company’s products include XPERIENCE, Blast X, SurgX and Bactisure. The XPERIENCE product is an antimicrobial solution used to prevent surgical site infections by rinsing away debris and microorganisms. SurgX Sterile Antimicrobial Gel is used to reduce surgical site and post-surgical infections by destroying planktonic and biofilm-based bacteria within the gel with sustained effectiveness for up to five days. BLASTX Antimicrobial Wound Gel provides wound management by maintaining a moist wound environment, which is conducive to wound healing.More

Articles & Videos

Next Science (ASX:NXS) appoints new Chief Executive and Managing Director

Next Science (ASX:NXS) has appointed Harry Thomas Hall IV (I.V.) as its newest Managing Director and Chief Executive Officer.

16 Jun 2023 12:00 (AEST)



(20min delay)
Last
32.5¢ 		Change
0.015(4.84%) 		Mkt cap ! $94.80M
Open High Low Value Volume
31.0¢ 32.5¢ 31.0¢ $3.532K 11.10K

Buyers (Bids)

No. Vol. Price($)
1 3049 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
32.5¢ 4394 1
View Market Depth
Last trade - 16.10pm 01/05/2024 (20 minute delay) ?
Last
32.0¢ 		  Change
0.015 ( 1.59 %)
Open High Low Volume
32.0¢ 32.5¢ 32.0¢ 1381
Last updated 15.59pm 01/05/2024 ?
NXS (ASX) Chart

Top Stories

Why Princeton Professor rates BlinkLab's autism & ADHD screening app

In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab's (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD.
Provident Aurum's off-market bid sends Sihayo shares soaring Small-cap mineral and gold explorer, Sihayo Gold (ASX:SIH) shares have soared, on news that the company has received intentions from Provident Aurum Pte to make an off-market takeover offer to acquire all shares of Sihayo Gold.
Recharged Prospects: 'Watts' on the horizon for copper & lithium The conversation goes much deeper that this title suggests - it explores everything from projections on aluminium & manganese, to what a Donald Trump government could mean for commodities markets.
Lithium Universe ends the quarter charged up for Quebec Refinery roll-out Lithium Universe has closed off the March quarter with a new Chief Financial Officer and strategically located land anchored for its lithium refinery in Quebec, Canada.
Carnarvon revs up for revised Dorado Development The Dorado discovery appears on again, with Carnarvon Energy announcing the JV completing a revision of the project’s design to optimise capital costs and accelerate FID by the end of 2024.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.